ELIZABETH HURTADO: Open Payments
NPI 1558074518 · NEWTOWN, PA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$3,388 in 151 payments from 19 companies in 2025. Trend: 2023 $1,348 · 2024 $2,161 · 2025 $3,388
Food & beverage: $3,388
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 34 | $621 |
| Janssen Biotech, Inc. | 24 | $536 |
| Ardelyx, Inc. | 16 | $430 |
| Madrigal Pharmaceuticals | 17 | $349 |
| QOL Medical, LLC | 15 | $312 |
| Janssen Scientific Affairs, LLC | 2 | $292 |
| Aimmune Therapeutics, Inc. | 13 | $206 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 5 | $101 |
| Lilly USA, LLC | 5 | $97 |
| Braintree Laboratories, Inc. | 3 | $92 |
Products named: TREMFYA, IBSRELA, REZDIFFRA, Sucraid, ZENPEP, LINZESS, RINVOQ, CREON.
Industry payments across PA — which companies pay providers there.
